1. Changes in periprostatic adipose tissue induced by 5α‐reductase inhibitors. (10th March 2017) Authors: Taussky, D.; Barkati, M.; Campeau, S.; Zerouali, K.; Nadiri, A.; Saad, F.; Delouya, G. Journal: Andrology Issue: Volume 5:Number 3(2017:May) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP-2013: Single fraction HDR BT boost using ultrasound plng for prostate cancer: dosimetrics and toxicity. (April 2016) Authors: Barkati, M.; Lauche, O.; Taussky, D.; Ménard, C.; Delouya, G. Journal: Radiotherapy and oncology Issue: Volume 119(2016)Supplement 1 Page Start: S951 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0038 Outcomes in focal vs. dose-painted salvage HDR brachytherapy for locally recurrent prostate cancer. (May 2021) Authors: Navarro, I.; Joseph, L.; Liu, Z.; Taussky, D.; Delouya, G.; Barkati, M.; Beauchemin, M.; Niazi, T.; Berlin, A.; Helou, J.; Raman, S.; Beliveau-Nadeau, D.; Kadoury, S.; Rink, A.; Chung, P.; Ménard, C. Journal: Radiotherapy and oncology Issue: Volume 158(2021)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PO-0232 Permanent seed prostate brachytherapy : long term results of a large single center. (May 2021) Authors: Taussky, D.; Delouya, G. Journal: Radiotherapy and oncology Issue: Volume 158(2021)Supplement 1 Page Start: S195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-0248 The one-hundred most-cited publications in prostate brachytherapy. (May 2021) Authors: Taussky, D.; Delouya, G.; Alcaidinho, A.; Donath, E. Journal: Radiotherapy and oncology Issue: Volume 158(2021)Supplement 1 Page Start: S206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PP-0156 HDR and LDR comparison as monotherapy in localized prostate cancer: PSA kinetic and late toxicity. (May 2021) Authors: Reynaud, T.; Hathout, L.; Carignan, D.; Barkati, M.; Martin, A.; Foster, W.; Lacroix, F.; Delouya, G.; Taussky, D.; Vigneault, E. Journal: Radiotherapy and oncology Issue: Volume 158(2021)Supplement 1 Page Start: S120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PP-0158 Registration accuracy of an integrated MR -TRUS navigation system for prostate HDR brachytherapy. (May 2021) Authors: Kadoury, S.; Lopera, D.; Shams, R.; Béliveau-Nadeau, D.; Delouya, G.; Boudam, K.; Carrier, J.; Menard, C. Journal: Radiotherapy and oncology Issue: Volume 158(2021)Supplement 1 Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Trial Participation is Not Associated with Better Biochemical Recurrence-free Survival in a Large Cohort of External Beam Radiotherapy-Treated Intermediate- and High-Risk Prostate Cancer Patients. Issue 1 (January 2023) Authors: Flammia, R.S.; Lavigne, D.; Tian, Z.; Saad, F.; Anceschi, U.; Gallucci, M.; Leonardo, C.; Preisser, F.; Mandel, P.; Chun, F.K.H.; Karakiewicz, P.I.; Delouya, G.; Taussky, D.; Hoeh, B. Journal: Clinical oncology Issue: Volume 35:Issue 1(2023) Page Start: e77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗